Opinion

Video

Androgen Receptor Signaling and Its Role in Driving Prostate Cancer Metastasis

Expert perspectives on androgen receptor signaling and its role in fueling prostate cancer metastasis along with a whiteboarding animation depicting this process.

Current Time 0:00
Duration 0:00
Loaded: 0%
Stream Type LIVE
Remaining Time 0:00
 
1x
    • Chapters
    • descriptions off, selected
    • captions off, selected
      Related Videos
      1 expert in this video
      Selecting Between Receptor Pathway Inhibitors for mHSPC
      1 expert in this video
      The Use of Ultra-Low PSA in Specific Patient Profiles
      2 experts are featured in this series.
      The MOA of TLX250
      1 expert is featured in this series.
      The importance of studying efficacy and safety of treatment in Black patients with mHSPC
      2 experts are featured in this series.
      The ZIRCON Trial
      1 expert is featured in this series.
      Translating the Trial: How Findings from ARANOTE May Inform Treatment Decisions
      4 experts in this video
      Case 3: A 49-Year-Old Man With Recurrent Non–Muscle-Invasive Bladder Cancer
      Bladder-Sparing Breakthroughs: Novel FDA-Approved Treatment Options for NMIBC
      Bladder-Sparing Breakthroughs: Novel FDA-Approved Treatment Options for NMIBC
      Expert Discussion on BCG-Unresponsive NMIBC
      Expert Discussion on BCG-Unresponsive NMIBC
      3 experts are featured in this series.
      Real-World Safety of Androgen Receptor Inhibitors in Nonmetastatic Castration-Resistant Prostate Cancer
      Related Content
      Survey: New NMIBC treatments face slow uptake
      June 2nd 2025

      Survey: New NMIBC treatments face slow uptake

      Benjamin P. Saylor
      Results of an exclusive Urology Times survey point to urologists preferring intravesical chemotherapy for treating BCG-unresponsive NMIBC.
      Pearls & Perspectives: Understanding and Improving Pelvic Health, with Diane Newman, DNP
      June 2nd 2025

      Pearls & Perspectives: Understanding and Improving Pelvic Health, with Diane Newman, DNP

      Amy M. Pearlman, MD
      Du Geon Moon, MD, PhD | Credit: Korea University College of Medicine
      April 27th 2025

      Sildenafil/Clomipramine Combo Boosts Outcomes in Premature Ejaculation

      Patrick Campbell
      A phase 3 trial reveals a combination therapy for premature ejaculation significantly enhances treatment outcomes.
      Pearls & Perspectives: From Guidelines to Practice—Navigating the TRT Treatment Spectrum, with Alex Tatem, MD
      May 17th 2025

      Pearls & Perspectives: From Guidelines to Practice—Navigating the TRT Treatment Spectrum, with Alex Tatem, MD

      Amy M. Pearlman, MD Alex Tatem, MD
      Explore the latest insights on testosterone therapy, its benefits, and practical applications from leading urologists in men's health.
      Nathan Lawrentschuk, MBBS, PhD | Credit: Epworth Healthcare
      April 26th 2025

      ADAM, a long-term, injectable male birth control, shows promise at AUA 2025

      Patrick Campbell
      A groundbreaking male contraceptive shows promising safety results, offering a reversible option for couples seeking effective birth control.
      Stacy Loeb, MD, MSc, PhD | Credit: NYU Langone Health
      April 26th 2025

      TikTok, social media does more harm than good for prostate cancer education

      Patrick Campbell
      Social media spreads significant misinformation about prostate cancer. Experts urge clinicians to provide trusted information sources.
      © 2025 MJH Life Sciences

      All rights reserved.